Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Inside information, Optomed Aurora with AEYE has received FDA clearance in the US

Optomed Plc Inside Information 30 April 2024 at 16.00, Helsinki Inside information, Optomed Aurora with AEYE has received FDA clearance in the US Optomed is pleased to announce that it has today received information that AEYE-DS with Optomed Aurora has received a 510(k) clearance from the U.S. Food & Drug Administration (FDA) to market and sell the AI camera.   “I'm thrilled to announce that our Optomed Aurora handheld fundus camera with AEYE’s AI has received FDA clearance. This milestone marks a significant advancement in healthcare technology as Aurora AEYE is the first

Update on financial status

Faron Pharmaceuticals Oy (“Faron” or the “Company”) Inside Information: Update on financial status · Further cash preservation extends runway into Q3/2024 · Understanding on conditional Waiver Extension reached with IPF, covering the Company until end of June 2024 to conduct the planned activities securing the further development of bexmarilimab in HMA-failed MDS Company announcement, 30 April 2024 at 16:00 (EEST) / 14:00 (BST) / 9:00 AM (EDT) Inside information     TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-

Humana receives competition clearance for the acquisition of Team Olivia Norge AS

On April 8 2024, Humana announced its intention to acquire Team Olivia Norge AS. Humana has now received approval for the acquisition from the Norwegian competition authority Konkurransetilsynet. The transaction is expected to be completed and consolidated in Humana’s accounts from 3 June 2024.The approval does not require any special conditions or concessions from Humana's side. Team Olivia Norge AS primarily operates in the areas of individual and family care as well as assistance services, reporting revenues of 913 million Swedish kronor[1)] in 2023. The company has approximately 2,

Global e-invoicing market growing 28% per year according to new report

PAGERO RELEASES THE 2024 BILLENTIS REPORT ON GLOBAL E-INVOICING AND TAX COMPLIANCE TO ITS COMMUNITYThe billentis report, authored by industry experts Bruno Koch and Marcus Laube, provides a comprehensive, research-driven overview of the state of e-invoicing and tax compliance today. Amongst other insights, the report estimates the value of the e-invoicing market to grow by on average 28% per year between 2024 and 2028 – at the end of which the annual transaction volume is estimated to be 184 billion e-invoices. Oscar Wegland, Chief Marketing Officer at Pagero, commented on the report,

DNB Bank ASA – Acquisition of shares by primary insiders

Oslo, 30 April 2024  Today, 30 April 2024, a total of 189,946 shares in DNB Bank ASA were acquired on behalf of certain leading employees and risk takers. The purchase was executed collectively at an average price per share of NOK 194.3405. The shares were acquired in accordance with the regulation on remuneration in financial institutions etc., which states that at least half of annual variable remuneration shall be awarded as shares and be subject to certain lock-up mechanisms. The employees have been given a compensation for decreased share value resulting from the lock-up at

Change in the number of shares and votes in Starbreeze AB

In accordance with Starbreeze’ articles of association, holders of series A-shares have the right to request that the shares be converted into series B-shares. The purpose of the conversion program is eventually to only have series B-shares issued. Such a conversion reduces the total number of votes in the company but does not affect owner’s share in terms of capital. When such conversion has taken place, the company has an obligation according to law to publish information about any changes on a monthly basis.During the current month, at the request of shareholder’s, 7,068,445 shares of

Invitation to Stendörren's interim report presentation for Q1 2024

Press release April 30, 2024 Stendörren publishes its interim report for January–Match 2024 on Friday May 3 at 07.00 CET and invites you to a webcast presentation and telephone conference on the same day at 10.00 CET. The company's CEO Erik Ranje and CFO Per-Henrik Karlsson will present the interim report and answer questions. The presentation is held in Swedish. The phone number to participate in the conference call: +46 8 5016 3827. Then dial meeting ID: #874 8087 0245. To ask a question to the CEO or CFO, please press *9 on the phone. To withdraw the question, you can do so by

New number of votes in AB Volvo

The number of votes in AB Volvo has changed due to the conversion of a total of 100 Series A shares to a total of 100 Series B shares. The conversions were implemented with the support of the opportunity for Series A shareholders to request conversion of Series A shares to Series B shares which was entered in the Articles of Association at the 2011 Annual General Meeting.Today, 30 April 2024, the last trading day of the month, there are a total of 2,033,452,084 registered shares in AB Volvo. Of these are 444,984,560 Series A shares and 1,588,467,524 Series B shares. The number of votes in

Heliospectra AB Prepares a Control Balance Sheet

TUE, APR 30, 2024 14:30 CEST The board of Heliospectra AB (publ) ("Heliospectra" or the "Company") has decided, in accordance with chapter 25 § 13 of the Swedish Companies Act, to prepare a control balance sheet for the Company's auditor to review.In connection with the compilation of the financial report for the first quarter of 2024, the board of Heliospectra has reason to suspect that the company's equity is less than half of the company's registered share capital. Due to this, the board, in accordance with Chapter 25 § 13 of the Swedish Companies Act, has initiated the process of

Form 8.3 - BHP Group Limited

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +-----------------------------------------------------+------------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+-----------------------------------------------------+------------------------+|(b) Owner or controller of interests and short |  ||positions disclosed, if different from

Form 8.3 - Anglo American Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +-----------------------------------------------------+-----------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+-----------------------------------------------------+-----------------------+|(b) Owner or controller of interests and short |  ||positions disclosed, if different from 1(a):

Genexis Sustainability Report 2023: EcoVadis Gold and approved Science-based Targets

This is a revised version of the press release about the Genexis sustainability report. This version contains a link to the website where it is published. In 2023 Genexis made significant progress in sustainability, reinforcing the company's commitments to proactively minimize our carbon footprint, develop the well-being of our people, and engage and promote a responsible supply chain.“We are proud of our sustainability efforts, and we aspire to be a frontrunner in our industry by setting an example of our genuine commitment and long-term ambition,” says Olivier van Duuren,

UK Monkey Forest's 'poo-nique' gut health research trumps Netflix new hit show!

Trentham Monkey Forest, a Staffordshire woodland home to 140 endangered Barbary macaques, is excited to join the conversation around gut health sparked by Netflix's new hit show, Hack Your Health: The Secrets of Your Gut.Just like the show's dedication to uncovering the mysteries of gut health, conservationists at Trentham Monkey Forest also take the digestive system very seriously, as they’ve been ‘hacking’ the monkey residents' health long before it was trendy, regularly testing their poo to ensure they're in tip-top shape. Trentham Monkey Forest is the largest primate enclosure in the

AutoStore: Notice of Annual General Meeting (corrected)

(Nedre Vats, 30 April 2024): AutoStore Holdings Ltd. (the "Company" or "AutoStore", OSE: AUTO) hereby gives notice of the convening of the annual general meeting to be held on Tuesday 21 May 2024 at 15:00 hours (CEST) a digital meeting.  Updated version of the release, including enclosed the notice of the annual general meeting, including the power of attorney and advanced voting form. The meeting will be conducted as a digital meeting only, accessible online via Lumi at https://dnb.lumiagm.com/153895667. All shareholders will be able to participate in the meeting, vote and ask

North Investment Group AB (publ) receives approval from bondholders in the written procedure for its outstanding SEK 285,000,000 bonds.

30 April 2024 – North Investment Group AB (publ) (the “Company”) announces that the written procedure initiated through a notice on 4 April 2024 (the "Written Procedure") regarding certain amendments to the terms and conditions for the Company's SEK 285,000,000 Senior Secured Floating Rate Bonds with ISIN SE0015938493 (the “Bonds”) has today been successfully completed.The Written Procedure was initiated in order to receive the bondholders' consent to implement, inter alia, an extension of the tenor of the Bonds, a new call structure, additional security as well as certain other amendments

Ahlstrom: Information regarding publication of January-March 2024 financial results

AHLSTROM PRESS RELEASE April 30, 2024, at 15:00 EEST Ahlstrom Holding 3 Oy will publish its January-March 2024 financial report on Wednesday, May 8, approximately at 12:00 EEST (11:00 CEST). The report will be available at www.ahlstrom.com/investors after publication.   A live audiocast and teleconference will be arranged on the same day, May 8 at 15:00 EEST (14:00 CEST). The event will be hosted by President and CEO Helen Mets, and CFO Niklas Beyes.  Questions to the management can be asked either via the chat box in the audiocast or in person by phone in the conference call.

Invitation to press- and audio conference regarding Skanska’s Interim report first quarter 2024 on May 8

Skanska’s Interim report first quarter 2024 will be released on Wednesday, May 8 at 07:30 am CEST. The report will be presented by Anders Danielsson, Skanska’s President and CEO, and Magnus Persson, CFO, at a press- and audio conference at 10:00 am CET at Skanska’s head office at Warfvinges väg 25 in Stockholm. The press conference will be webcasted live at www.skanska.com/investors, where it also will be posted shortly afterwards. Participate in the audio conference, with the possibility to ask questions: To improve the quality of sound during the Q&A for participants and

BerGenBio ASA: Notice of Annual General Meeting

Bergen, Norway – 30 April 2024: BerGenBio ASA (OSE:BGBIO) will be holding its Annual General Meeting virtually on 23 May 2024 at 16:00 hours (CEST).   The notice, registration form and power of attorney are attached to this release. The notice will be sent to all registered shareholders and the notice in addition to other attachments are available on the Company’s website: https://www.bergenbio.com/investors/general-meetings   All shareholders are encouraged to exercise their shareholder rights, either through advance electronically voting through VPS Investor Services, by using

Board Change

Faron Pharmaceuticals Ltd. (“Faron” or the “Company”)     Board Change     Company announcement, April 30, 2024 at 15:00 (EEST) / 1:00 PM (BST) / 8:00 AM (EDT)    TURKU, FINLAND / BOSTON, MA  Further to the announcement of 8 April 2024, Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate anti-tumor immunity in hematological and solid tumor microenvironments, is pleased to announce the appointment of Dr. Juho Jalkanen as director and Chief

HANZA presents interim report May 7

HANZA will publish its interim report for the first quarter of 2024 on May 7 at 7.30 am CET. In connection with the report, HANZA invites investors, analysts and media to a combined conference call and audiocast at 11.00 am CET the same day.The report will be presented by CEO Erik Stenfors and CFO Lars Åkerblom. The presentation will be held in English. Time: Tuesday, May 7 at 11:00 a.m. Participate via webcast: https://financialhearings.com/event/48787 Participate via teleconference: Register via this link 

OKEA ASA: Successful Placement of Senior Secured Bond Issue

(Trondheim, 30 April, 2024): OKEA ASA (OSE: OKEA) ("OKEA" or the "Company") has successfully placed a new USD 125 million senior secured bond issue with a tenor of 4 years. The new bond will carry a fixed interest rate of 9.125% per annum. The transaction attracted strong interest from Nordic and international investors and was significantly oversubscribed. Net proceeds from the bond issue will be used to fund planned investments related to the recently sanctioned Bestla (previously named Brasse) development and general corporate purposes. In connection with the bond issue, the Company

AutoStore: Notice of Annual General Meeting

(Nedre Vats, 30 April 2024): AutoStore Holdings Ltd. (the "Company" or "AutoStore", OSE: AUTO) hereby gives notice of the convening of the annual general meeting to be held on Tuesday 21 May 2024 at 15:00 hours (CEST) a digital meeting. Please find enclosed the notice of the annual general meeting, including the power of attorney and advanced voting form. The meeting will be conducted as a digital meeting only, accessible online via Lumi at https://dnb.lumiagm.com/153895667. All shareholders will be able to participate in the meeting, vote and ask questions from desktop devices,

Photocure ASA – Notice of the Annual General Meeting 23 May 2024

Oslo, Norway, 30 April 2024: Photocure ASA (OSE: PHO), calls for the annual general meeting of Photocure ASA to be held on 23 May 2024 at 17:00 hours (CEST), virtual through the general meeting portal administered by Euronext Securities Oslo (the "Euronext Securities Portal").The general meeting will be webcasted live and a link will be available on the company's website in due time in advance of the general meeting. It will not be possible to attend in person. Shareholders may also vote in advance or submit a proxy with voting instructions. The notice convening the general meeting,

Brain+’ CST-Assistant cited in leading Nordic Life Science magazine as an impactful health tech intervention for managing dementia

Copenhagen, Denmark, 30 April 2024 – Brain+ A/S (Nasdaq First North: BRAINP)    ·Health tech, A.I. and Computer-Brain interfaces are making an impact on CNS disease treatments, beyond the traditional pharmaceutical treatments. (NLS magazine)   ·The Brain+ CST-Assistant, which enables software-based delivery of Cognitive Stimulation Therapy for people with dementia, is highlighted as an impactful health tech treatment (NLS magazine)   ·While CST itself is an effective and globally recognized dementia therapy, the future holds potential for combining it with

There are no items matching the current filter
There are no more items matching the current filter
Back to top